Roslin Cellab, Roslin BioCentre, Roslin, Midlothian EH25 9PP, UK Adeno-associated virus (AAV) capsid assembly occurs in the nucleus. Newly synthesized capsid proteins VP1, VP2 and VP3 contain several basic regions (BRs), which may act as nuclear localization signals (NLSs). Mutation of BR2 and BR3, located at the VP1 and VP2 N termini, marginally reduced nuclear uptake of VP1 or VP2, but not of VP3, when expressed in the context of the whole AAV type 2 (AAV2) genome. Combined mutation of BR1, BR2 and BR3 resulted in capsids with slightly reduced amounts of VP1. Expression of isolated VP1/2 N termini revealed an influence of BR3 on nuclear transport, whilst BR1 or BR2 had no effect. However, deletion of an N-terminal fragment in front of the BR elements strongly reduced nuclear uptake of VP1/2 N termini. Mutation of BR4, present in all three capsid proteins, led to their retention in the cytoplasm and to the formation of speckles, resulting in a lack of capsid formation and a significant reduction in VP levels. In a VP fragment comprising BR2, BR3 and BR4, the BR4 element was not necessary for nuclear localization. Mutation of BR5 in the C-terminal part of the VPs resulted in a speckled protein distribution in the nucleus, strongly reduced capsid assembly, and low VP1 and VP2 levels. Taken together, these results showed that BR2 and BR3 have a weak influence on nuclear transport of VP1 and VP2, whilst combined mutation of BR1, BR2 and BR3 influences the stoichiometry of VPs in assembled capsids. BR4 and BR5 play a crucial role in capsid assembly but have no NLS activity.
INTRODUCTION
The capsid of the parvovirus adeno-associated virus type 2 (AAV2) is composed of 60 subunits of the structural proteins VP1, VP2 and VP3 arranged in a T51 icosahedral symmetry (Kronenberg et al., 2001; Xie et al., 2002) . The capsid proteins are expressed in an approximate ratio of 1 : 1:10, in which they are also incorporated into the capsid (Buller & Rose, 1978) . They are translated from an overlapping cap ORF with alternative translational start sites for the three VPs and a common stop codon. VP1 translation is initiated at an ATG of the alternatively spliced minor mRNA (2.4 kb mRNA) (Becerra et al., 1988; Cassinotti et al., 1988; Trempe & Carter, 1988) . VP2 and VP3 are translated from the major spliced mRNA (2.3 kb mRNA) using a weak initiation codon for translation of VP2 (ACG) and a downstream ATG codon for translation of VP3 (Becerra et al., 1985; Muralidhar et al., 1994) . It is experimentally well established that capsid assembly of parvoviruses occurs in the cell nucleus of infected cells (reviewed by Kleinschmidt & King, 2006; Valle et al., 2006) . As nuclear localization of capsid proteins is probably required for capsid assembly, the capsid proteins should have properties that provide their transport into the nucleus.
Initial studies have shown that VP1 or VP2 expressed alone efficiently accumulates in the nucleus, whilst VP3 expressed alone only partially enters the nucleus and predominantly stays in the cytoplasm (Ruffing et al., 1992) . Co-expression of VP3 with VP1 or VP2 increases nuclear transport of VP3. This observation led to the interpretation that, under natural conditions, VP1 or VP2 co-transports VP3 into the nucleus and thereby contributes to the assembly process and to the correct stoichiometry of the VPs forming the capsid. The nuclear localization signals (NLSs) of VP1 and VP2 remain to be fully determined. They contain three short basic regions (BR1-BR3; Fig. 1 ) which resemble classical NLSs (Grieger et al., 2006; Sonntag et al., 2006; Wu et al., 2000) . Based on deletion analysis within the N terminus of VP2, BR3 (comprising amino acid sequence PARKRL) has been suggested to mediate nuclear transport of VP2 and probably also of VP1, as VP1 and VP2 have this sequence in common (Hoque et al., 1999) . It has also been reported that fusion of PARKRL to GFP improved nuclear transport of GFP. Chemical coupling of peptides displaying the PARKRL sequence, however, did not direct ovalbumin or serum albumin into the nucleus, whereas two other peptides displaying BR1 or BR2 had nuclear transport activity (Sonntag et al., 2006) . A fourth basic region (BR4), located on a sequence stretch common to all three capsid proteins, forms a potential conformationdependent nuclear localization motif (NLM), which might be activated in VP1 and VP2 but not in VP3. Mutagenesis of BR4 was found to inhibit virion assembly but not nuclear accumulation of newly synthesized VPs (Grieger et al., 2006) . A fifth small basic region (BR5), located at the C terminus of the capsid proteins, was found to be required for capsid assembly and nuclear translocation of VPs in autonomous parvoviruses (Lombardo et al., 2000; Yuan & Parrish, 2001 ) but has not yet been analysed for AAV.
Nuclear transport of proteins occurs through the nuclear pore complex, a large and dynamic multi-protein structure, embedded in the nuclear envelope (Tran & Wente, 2006) . To permit nuclear transport through the nuclear pore complexes, proteins have to interact with cytoplasmic transport receptors -importins/karyopherins -via specific NLS interaction domains (Fried & Kutay, 2003; Lee et al., 2006; Nigg, 1997) . The classical NLS, determined initially for the simian virus 40 (SV40) large T antigen, is composed of a series of basic amino acids flanked by a b-turn or a loop (Cokol et al., 2000; Dingwall & Laskey, 1991; Garcia-Bustos et al., 1991) . Besides classical NLSs, non-classical ones also have to be considered.
Recently, it has been shown that the assembly activating protein (AAP) of AAV can target VP3 to the nucleolus and aids capsid assembly (Sonntag et al., 2010) . Under these conditions, a large fraction of VP3 stays in the cytoplasm and does not assemble into capsids. In addition, during productive infection, not all VP3 proteins accumulate in the nucleus (Wistuba et al., 1997) . The overlap of the intrinsic properties of the capsid proteins for nuclear transport with their ability to interact with AAP adds a further layer of complexity to the question of which sequences direct the AAV VPs to the nucleus.
In this study, we analysed the involvement of the five BRs on nuclear transport of newly synthesized capsid proteins of AAV2. Whilst BR1, BR2 and BR3 alone were not absolutely required for nuclear transport of capsid proteins, mutation of all three BR sequences led to a reduced amount of VP1 and VP2 in assembled capsids. In the context of the entire AAV genome, mutation of BR4 prevented nuclear transport of VPs. The C-terminal basic residues comprising BR5 did not affect nuclear transport but did affect intranuclear localization and probably also folding of the VPs. 
RESULTS

Analysis of VP1/2 N-terminal BRs as potential NLSs of capsid proteins
The VP1/2 N termini harbour highly conserved sequence elements (BR1-BR3), which are candidate NLSs for the capsid proteins (Fig. 1) . Deletion mapping of VP2 has suggested that BR3 acts as the NLS for VP2 (Hoque et al., 1999) . The contribution of BRs to the nuclear transport of newly synthesized capsid proteins has not yet been studied in the presence of all three full-length VPs. In this study, candidate NLSs were analysed by site-directed mutagenesis (Table 1) . Nuclear transport of VP1, VP2 and VP3 was monitored by indirect immunofluorescence using mAbs detecting VP1 only (mAb A1), VP1 and VP2 (mAb A69) or all three capsid proteins (mAb B1) (Wobus et al., 2000) ( Fig. 2a) . Assembled capsids were visualized using mAb A20 (Wistuba et al., 1997) .
Representative fluorescence images of wt and various BR mutants are shown in Fig. 2 2 ) localized solely in the nucleus, as indicated by mAb A69 staining, whilst a fraction of VP1 was clearly retained in the cytoplasm according to mAb A1 staining (BR3 2 and BR2 2 3 2 ). This suggested a role for BR3 in VP1 nuclear trafficking. mAb B1 visualized wt as well as mutant capsid proteins in the nucleus and small amounts in the cytoplasm.
Taken together, changing BR2 and BR3 into acidic clusters had an influence on the nuclear transport of VP1 and VP2. However, the overall nuclear transport of VPs was not altered dramatically. This indicated that the capsid proteins must have additional sequence elements that provide sufficient nuclear transport activity, ensuring nuclear accumulation of the VPs.
BR2 and BR3 influence VP stoichiometry in assembled capsids
Staining of transfected cells with mAb A20 indicated that capsid formation occurred with all mutants (Fig. 2b) . Quantification of capsid formation by a mAb A20 capsid ELISA (Fig. 2c) supported this observation. This was in agreement with and extends previous findings showing unaltered capsid formation of mutants having amino acid changes in only one BR at a time (Grieger et al., 2006; Wu et al., 2000) . To test whether mutation of BR1, BR2 and BR3 had an influence on the stoichiometry of VPs in assembled capsids, immunoprecipitated capsids were analysed by Western blotting (Fig. 2d) . The presence of bands as well as the calculated VP ratio showed that the VP composition of the two combined BR2/BR3 mutant capsids was changed: the capsids of mutants BR2 2 3 2 and BR1 2 2 2 3 2 showed a slightly reduced VP1 and VP2 content compared with the wt. Whilst wt capsids were composed of VP1, VP2 and VP3 at a ratio of approximately 14 : 45 : 100, the capsids of BR2 2 3 2 and BR1 2 2 2 3 2 had a VP1 : VP2 : VP3 ratio of 8 : 17 : 100 and 3 : 25 : 100, respectively, further supporting the notion that BR2 and BR3 may influence nuclear transport of VP1 and VP2. The unexpected migration of VP2 in mutants BR3 2 and BR1 2 3 2 by SDS-PAGE may have resulted from a strong conformational influence of the acidic amino acids, which was not completely overcome by SDS treatment. However, this phenomenon was not observed in other BR mutants.
Nuclear transport of VP1/2 N termini
To analyse further the contribution of BR1, BR2 and BR3 to nuclear transport of VPs, we expressed the His-tagged VP1/2 N terminus alone (Fig. 3a) . Subcellular protein localization was visualized using mAb A69. VP1/2 N termini were predominantly -but not exclusivelylocalized to the nucleus (in 81 % of transfected cells). Approximately 20 % of the cells showed both nuclear and cytoplasmic distribution of the protein (Fig. 3b, c) . A similar percentage of restricted nuclear localization was VPs were detected by mAb B1 and the bands were quantified by ImageJ gel analysis. As VP3 levels were constant in all mutants, the intensity of each band representing VP3 was set to 100, and relative VP2 and VP1 ratios were calculated accordingly. 2 and BR2 2 3 2 mutants localized to both the nucleus and the cytoplasm, meaning that here the ratio of nuclear to cytoplasmic localization was reversed. This indicated a stronger contribution of BR3 to the nuclear transport capacity of the VP1/2 N termini than BR1 or BR2. However, the relative amounts of the different mutants in the nucleus and cytoplasm suggested that an additional parameter, as well as the NLS, influenced their nuclear transport. It is possible that the conformation of the protein fragment also plays a role. This interpretation was supported by the DXhoI mutant, which retained the potential NLS sequence of BR3 but was devoid of aa 10-73 of VP1. This mutant showed a predominant -but not exclusive -cytoplasmic localization (in 68 % of transfected cells). To test whether this amino acid sequence harboured an NLS, we coupled a peptide comprising aa 20-44 (RQWWKLKPGPPPPKPAERHKDDSRC) to fluorescently labelled BSA and injected this into the cytoplasm of HeLa cells. In contrast to BSA coupled to the NLS of SV40 large T antigen, this peptide did not transport BSA to the nucleus (data not shown). From these observations we concluded that BR3, and possibly sequences that were deleted in the DXhoI mutant, contribute to nuclear transport of the VP1/2 N termini. Alternatively, the protein conformation affected by the DXhoI deletion may have an influence on the cellular distribution of the proteins. An influence of protein conformation on the NLS activity of BR elements has also been postulated in a previous report (Sonntag et al., 2006) .
BR4 affects nuclear accumulation of capsid proteins
As mutation of BR1-BR3 had no dramatic effect on the overall nuclear transport of capsid proteins, BR4, which is common to all three capsid proteins, might serve as a conformation-dependent NLM, providing additional NLS activity when VP1 and VP2 are present. BR4 is located in a b-sheet between residues 307 and 312, structurally similar to the NLM described for minute virus of mice (MVM; Lombardo et al., 2000) (Fig. 4a) . The residue R238 is located in close proximity to this motif, potentially also contributing to a basic sequence motif consisting of R238, R307, P308, K309 and R310. The basic amino acids of this motif were converted to A, N or E in the BR4 mutants (Table 2 ) and the mutants were analysed for cellular localization and capsid assembly. VP expression of BR4 mutants R/RPAR and A/RPKR was comparable to that of AAV2 wt (Fig. 4b) . However, in Western blot analysis of those BR4 mutants carrying two or more amino acid exchanges of basic residues, additional bands appeared just below VP1 and VP2. These minor bands were possibly the result of degradation.
The mutations K309A or R238A alone had no visible influence on nuclear accumulation of VPs (Fig. 4d) . BR4 mutant R/RPAR, together with the triple mutant BR1 2 2 2 3 2 , also showed no change in nuclear and nucleolar staining with mAbs A1, A69 and A20 (data not shown). However, combination of mutations R238A and K309A (BR4 mutant A/RPAR) resulted in a significantly reduced nuclear accumulation of VP1, VP2 and VP3 iñ 70 % of analysed cells (Fig. 4d and Fig. S1 , available in JGV Online). A similar result was obtained with BR4 mutant R/RPNN, a mutant that has been described previously (Grieger et al., 2006) . By immunofluorescence, we saw a reduction in the nuclear transport of VP1 (mAb A1 staining) and VP1/2 (mAb A69 staining) and a loss of nucleolar accumulation of capsid proteins. An even stronger effect on nuclear transport of VPs was observed in BR4 mutants R/APAR, R/APAA and R/EPEE. Here, no nuclear staining with mAb B1 could be detected in .90 % of the analysed cells (Fig. S1a) . Remarkably, the cytoplasmic staining of 70-80 % of these mutants was intensively speckled (Fig. S1b) , indicating either the formation of capsid protein aggregates or interactions with cytoplasmic structures.
Capsid assembly, analysed by mAb A20-based immunofluorescence and ELISA, correlated with nuclear accumulation of VPs (Fig. 4c) . BR4 mutant A/RPAR showed a 10-fold and mutant R/RPNN a 10-50-fold reduction in capsid titres, whereas capsid formation of BR4 mutants R/APAR, R/APAA and R/EPEE was below the level of detection. A defect in capsid assembly has already been reported for different exchanges of BR4 basic residues (Grieger et al., 2006; Wu et al., 2000) . From these observations, however, it is hard to tell whether the lack of VP nuclear accumulation is the cause or effect of deficient capsid assembly. For autonomous parvoviruses, it has been shown that misfolded capsid proteins that are unable to assemble cannot accumulate efficiently in the nucleus, and instead are found in the cytoplasm (Lombardo et al., 2002; Yuan & Parrish, 2001 ).
Because the BR4 sequence motif overlaps the AAP sequence encoded by ORF2 (Sonntag et al., 2010) , it is conceivable that mutations of BR4 also affect the sequence of AAP. Therefore, we co-expressed AAP, encoded on a separate plasmid, with BR4 mutant R/APAA or R/EPEE. AAP expression did not rescue the mislocalization of the mutated VPs and also did not resolve the speckled pattern visible in immunolocalization (data not shown).
BR4 is not necessary to mediate nuclear transport of a VP subfragment If BR4 acts as an NLS, one would expect that VP3 alone should be able to accumulate in the nucleus. However, as shown previously, VP3 expressed without VP1 and VP2 did not accumulate in the nucleus (Ruffing et al., 1992; Sonntag et al., 2010) . This result might indicate that the BR4 motif in VP3 is present in an inactive conformation and might require the N-terminal capsid protein sequences to become activated to act as an NLS. In addition, the cytoplasmic speckle formation of BR4 mutants did not allow discrimination between a role of BR4 in nuclear transport and aggregate formation due to conformational misfolding. A correlation between protein misfolding and a consequent inability to enter the nucleus is possible. To evaluate the role of BR4 without the interference of fulllength capsid proteins, we fused a portion of the capsid proteins comprising the VP2 N terminus, the VP3 N terminus and the BR4 element (EcoNI-BsiWI fragment, comprising aa 133-352 of the VP sequence) to GFP and analysed VP subfragment accumulation in the nucleus. Expression of the GFP fusion proteins was confirmed by Western blotting, and nuclear translocation was analysed by indirect immunofluorescence using mAb A69 (Fig. 5) . In contrast to VP3 alone, the EcoNI-BsiWI fragment of VP was located exclusively in the cell nucleus. Interestingly, mutation of BR4 did not prevent nuclear accumulation of this capsid protein fragment, leading to the conclusion that BR4 cannot serve as the only NLS (Fig. 5c ). This result suggested that the lack of nuclear localization of the BR4 mutants in the context of full-length VPs might rather be caused by cytoplasmic retention due to protein misfolding and not by the loss of an NLS. In the EcoNI-BsiWI fragment, BR2, BR3 and BR4 might form a multipartite NLS, exerting NLS activity in concert with or alternatively to each other. Mutation of BR2 prevented nuclear localization and induced aggregate formation. The VP fragment containing mutated BR3 was not detectable by immunofluorescence by three different antibodies and also not by Western blotting (Fig. 5b, c) .
BR5 plays a role in intranuclear distribution of capsid proteins
K688, K692 and R693 are basic amino acids of BR5 (Fig.  6a) , located at sequence positions homologous to the NLM identified in MVM (Lombardo et al., 2000) . The VPs in which K688 and K692 were changed to A (BR5 2 ) in the context of full-length capsid proteins clearly entered the nucleus; however, they showed a speckled distribution (Fig.  6d) . The speckled structures resembled accumulated ubiquitin-conjugated proteins that had been marked for proteasome-mediated degradation, as has been described previously for BR-mutated VPs of MVM (Lombardo et al., 2002) . Interestingly, steady-state levels of VP1 and VP2 were very low (Fig. 6b) , and capsid assembly was reduced by two to three orders of magnitude (Fig. 6c) . Generally, in all preparations of VPs in which a speckled cellular distribution was observed, a low level of VP1 and VP2 was noted. These findings indicated an association of the speckled structures with degradation processes.
DISCUSSION
Newly synthesized capsid proteins have to enter the nucleus where the environment for capsid formation is provided. Studying signal sequences involved in nuclear translocation in the context of full-length AAV capsid proteins is challenging for several reasons: the three VPs can interact with each other, can interact with AAP (Sonntag et al., 2010) and have the tendency to form aggregates that prevent normal intracellular transport processes. In addition, it is possible that multiple NLSs exist. In contrast, separate analysis of VPs or VP fragments ). (d) Indirect immunofluorescence of HeLa cells expressing VPs that lead to the formation of AAV2 wt or BR4 mutants. VP1 N termini were detected by mAb A1, VP1/2 N termini by mAb A69, free capsid proteins by mAb B1 and assembled capsids by mAb A20 immunostaining.
Nuclear transport of capsid proteins reveals only a partial aspect of the natural process and may lead to simplifications and misleading conclusions. We decided to use both approaches, namely analysis of VP transport in the context of all AAV2 proteins and as isolated fragments. This allowed us to address some of the questions related to potential NLSs of the AAV2 capsid proteins.
BR1, BR2 and BR3 as potential NLSs
BR1, BR2 and BR3 have been discussed previously as possible NLSs for the AAV capsid proteins (Grieger et al., 2006; Hoque et al., 1999; Ruffing et al., 1992) and some experimental evidence has been provided supporting such a function. The most direct approach suggested that BR3 is necessary and sufficient for nuclear transport of VP2 (Hoque et al., 1999) . This conclusion was based on the loss of VP nuclear localization following progressive deletion of the VP2 N terminus, and on the fusion of BR3 to GFP, which directed GFP into the nuclei of COS cells. According to our study, there is no absolute requirement for BR1, BR2 or BR3 for nuclear transport of VPs when expressed in the context of all capsid proteins. This is in agreement with Table 2 . AAV2 BR4 mutants used in this study.
Virus
aa 238 aa 307-312 previous experiments reporting normal capsid formation after mutation of these elements (Grieger et al., 2006; Sonntag et al., 2006; Wu et al., 2000) . However, the partial cytoplasmic localization of VP1 or VP2 of mutants BR2 2 , BR3 2 , BR1 2 2 2 and BR2 2 3 2 (Fig. 2) could be due to a redundant and weak NLS activity of BR2 and BR3, similar to the BC2 element of MVM (Lombardo et al., 2002) . Furthermore, BR2 and BR3 might act more strongly in concert as a bipartite NLS. The reduced VP1 content of capsids assembled from BR1 2 2 2 3 2 VPs also indicated an influence of these BR motifs on nuclear transport of capsid proteins. Alternatively, an influence on the capsid protein conformation due to the conversion of basic residues into acidic residues may have indirectly impaired nuclear transport.
In contrast, mutagenesis of separately expressed VP1/2 N termini revealed an influence of BR3 mutation on nuclear localization (Fig. 3) . Deletion of an upstream sequence, involving the region homologous to BC1 in MVM (showing NLS activity; Lombardo et al., 2002 ) also significantly reduced nuclear translocation of the VP1/2 N termini (Fig. 3) . Nevertheless, neither sequence (aa 20-43 of VP1 and BR3) provided nuclear transport activity when coupled to heterologous proteins such as BSA or ovalbumin (Sonntag et al., 2006) . In addition, BR3 coupled to GFP did not result in nuclear targeting of GFP (data not shown). Single BR1 and BR2 peptides, as well as a combined BR2/BR3 peptide were, however, able to translocate BSA into the nucleus (Sonntag et al., 2006) . These rather divergent results cannot easily be explained. However, they suggest a role of BR2 and BR3 for nuclear transport of VPs, although this function is probably dependent on the cooperative interaction with other VPencoded nuclear transport signals. Thus, BR2 and BR3 function could be influenced by the capsid protein conformation. Also, when comparing the results of VPs expressed in the whole-genome context versus expression of individual protein fragments, a potential influence of adenovirus co-infection (in case of whole-genome expression only) on intracellular VP localization might be considered.
Overall, our results are in accordance with the observations made with the homologous BC elements of the autonomous parvoviruses MVM and canine parvovirus (CPV). BC2 and BC3 of MVM, corresponding to BR1 and BR2 of AAV, are not required for nuclear transport of capsid proteins " could not be determined because the number of capsids formed was below the detection limit (5¾10 7 capsids ml . VP1 N termini were detected by mAb A1, VP1/2 N termini by mAb A69, free capsid proteins by mAb B1 and assembled capsids by mAb A20 immunostaining.
Nuclear transport of capsid proteins (Lombardo et al., 2002) . A NLS homologous to BC1 of MVM or CPV, which cooperates in MVM with the NLM for VP1 nuclear transport (Lombardo et al., 2000 (Lombardo et al., , 2002 , is missing in AAV but may be contained in the sequences deleted in the DXhoI mutant discussed above. The BR3-homologous sequences of MVM and CPV, referred to as BC4 (Lombardo et al., 2002; Valle et al., 2006) , were also not required for VP nuclear transport in the context of fulllength VP1. In addition, coupling of the corresponding peptide of CPV to BSA did not provide nuclear transport of the carrier proteins (Vihinen-Ranta et al., 1997) . The observation of Hoque et al. (1999) that N-terminal deletions of BR3 lead to a loss of VP2 nuclear transport may need an alternative interpretation. These deletions also induced a loss of AAP expression, which may have an impact on nuclear transport of the truncated VP2/VP3 molecules and thus explain the concomitant loss of capsid assembly. The interaction of AAP and VP3 does not lead to a general accumulation of VPs in the nucleus (Sonntag et al., 2010) but rather to targeting of a fraction of VPs to the nucleolus. The effect of AAP on simultaneously expressed VP2 and VP3, however, has not been studied.
Do AAV2 capsid proteins have a NLM?
Lombardo et al. (2000) showed that NLM, a conformational -not a linear -signal, located at the C terminus of capsid proteins, is the dominant nuclear transport signal of MVM VPs. Sequence alignment of MVM and AAV2 capsid protein sequences did not reveal an NLM-homologous sequence in the C terminus of AAV2 capsid proteins. However, we noted a group of three basic amino acids (K688, K692 and R693 in BR5; see also Kerr et al., 2006) in the homologous sequence region. Mutation of BR5 did not prevent nuclear accumulation of capsid proteins but led to a speckled appearance in the nucleus, reduced VP levels and reduced capsid assembly. This suggests that the basic residues of BR5 play a role in forming a VP conformation or oligomerization status in the nucleus that is needed for capsid assembly but are obviously not required in the cytoplasm for VP nuclear transport. It is not yet clear which nuclear proteins or structures interact with capsid proteins to aid assembly. BR4 of AAV2 (aa 307-312) is structurally similar to the NLM of parvovirus MVM. It differs from the NLM in that it comprises three basic amino acids besides R238. It is located on a b-strand and is sensitive to conformational changes due to the fact that R238 contributes to the basic character of BR4. Monitoring of capsid proteins by indirect immunofluorescence clearly showed cytoplasmic VP aggregate formation of several BR4 mutants and a lack of VP nuclear localization. This may in turn have hindered capsid assembly and favoured capsid protein degradation. The cytoplasmic speckled distribution pattern of BR4 mutants resembles the phenotype of nuclear transport-defective VP1 in MVM, which was associated with ubiquitination and possibly VP degradation (Lombardo et al., 2002) . Our results indicated that an intact BR4 may be required for nuclear accumulation of capsid proteins. However, our data could not reveal whether disturbed nuclear targeting of VPs is a cause or an effect of missing capsid assembly. In this regard, we could not completely confirm the interpretation, reported by Grieger et al. (2006) , of BR4 being required only for capsid assembly and not being involved in nuclear transport.
Taken together, our search for NLSs of newly synthesized capsid proteins of AAV2 revealed a complex situation in which none of the investigated candidate signal sequences showed a dominant NLS activity. Contributions of BR2 and BR3 are likely but may be obscured by VP conformations or be complemented by non-conventional and undetected NLSs. Mutation of two candidate NLM sequences, BR4 and BR5, led to capsid proteins located in speckles in the cell, indicating an indirect influence on the conformation of the VP structure, rather than an influence on the nuclear transport activity.
METHODS
Cell culture. HeLa and 293T cells were maintained at 37 uC and 5 % CO 2 in Dulbecco's modified Eagle's medium supplemented with 10 % FCS, 100 U penicillin ml 21 , 100 mg streptomycin ml 21 and 2 mM Lglutamine.
Plasmids and site-directed mutagenesis. The plasmid pTAV2.0 (Heilbronn et al., 1990) 
, BR4
2 and BR5 2 are based on pTAV2.0 containing the designated mutations. Mutagenesis was performed using a QuikChange Site-directed Mutagenesis kit (Stratagene) according to the manufacturer's instructions. Mutations were verified by DNA sequencing. The plasmid pHis-VP1/2 N was constructed by a PCR amplifying the VP1/2 N terminus from pTAV2.0, containing the designated mutations (forward primer: 59-CGGAATTCCGGATG-GCTGCCGATGGTTATC-39, reverse primer: 59-GCTCTAGAG-CCTACGTATTAGTTCCCAGACCA-39) and subcloning of the PCR product into pcDNA4/HisMaxC (Invitrogen) via EcoRI/XbaI restriction sites. The plasmid pVP2N-GFP has been described previously (Sonntag et al., 2010) .
Preparation of virus supernatants and whole-cell extracts.
Transfection of 293T cells and preparation of virus supernatants was carried out as described previously (Sonntag et al., 2006) . In brief, 293T cells were transfected with 6 mg plasmid DNA and superinfected with adenovirus type 5 (Ad5) at an m.o.i. of 10. After 48 h, cells were harvested in the medium and lysed by three freeze-thaw cycles (280/ 37 uC). For preparation of whole-cell extracts, transfected and superinfected cells were harvested in the medium at 48 h posttransfection. A sample of 700 ml of the cell suspension was centrifuged at 500 g for 5 min, and the pellet was washed with PBS and resuspended in 60 ml 26 protein sample buffer [100 mM Tris/HCl (pH 8), 2 mM EDTA, 20 % glycerol, 10 % b-mercaptoethanol, 4 % SDS, 0.02 % bromophenol blue] and 40 ml PBS. Samples were denatured at 99 uC for 5 min, before cellular debris was sedimented at 17 000 g for 5 min.
Virus titration and analysis of viral protein expression. Capsid titres were determined from virus supernatants by an AAV2-specific ELISA (Progen) as described by Grimm et al. (1999) . Expression of On: Sun, 16 Dec 2018 00:40:20 capsid proteins VP1, VP2 and VP3 was analysed from whole-cell extracts by Western blotting using the mAb B1 (Wistuba et al., 1995) and expression of VP2 N terminus-GFP fusion proteins using the mAb A69 (Wistuba et al., 1997) and an anti-GFP mAb (clone B-2; Santa Cruz Biotechnology).
Subcellular localization of viral proteins by immunofluorescence microscopy. HeLa cells (7610 4 per well) were seeded in 24-well plates containing coverslips. After 24 h, cells were transfected using Lipofectamine 2000 transfection reagent according to the manufacturer's instructions (Invitrogen). For analysing nuclear transport in the context of the full-length AAV2 genome, the medium was removed at 4-6 h post-transfection and replaced by fresh medium containing Ad5 at an m.o.i. of 1. Cells were cultivated for a further 24 h. Fixation with 100 % methanol or 2 % paraformaldehyde and immunostaining was performed as described previously (Sonntag et al., 2006 (Sonntag et al., , 2010 . Images were taken with a Leica TCS SP2 or a Zeiss LSM 710 microscope using a 663 oilimmersion objective and the filter settings for the corresponding fluorescent dyes. Images were processed with Adobe Photoshop CS and ImageJ software. Processing was carried out simultaneously on the images to avoid selective shifts of brightness or contrast.
Graphics. Images were prepared using RASMOL software version 2.7.2.1.1 (Sayle & Milner-White, 1995) . The structure of AAV2 was obtained from the Brookhaven Protein Data Bank (entry 1LP3; Xie et al., 2002) .
